Literature DB >> 22242233

Meeting of the Strategic Advisory Group of Experts on Immunization, November 2011 – conclusions and recommendations.

.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22242233

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  21 in total

1.  Reply to Nalin.

Authors:  John T Schiller; Douglas R Lowy
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

Review 2.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 3.  Pneumococcal disease and use of pneumococcal vaccines in Taiwan.

Authors:  Sung-Hsi Wei; Chuen-Sheue Chiang; Chyi-Liang Chen; Cheng-Hsun Chiu
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

Review 4.  Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Authors:  Jennifer D Loo; Laura Conklin; Katherine E Fleming-Dutra; Maria Deloria Knoll; Daniel E Park; Jennifer Kirk; David Goldblatt; Katherine L O'Brien; Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

Review 5.  Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.

Authors:  Katherine E Fleming-Dutra; Laura Conklin; Jennifer D Loo; Maria Deloria Knoll; Daniel E Park; Jennifer Kirk; David Goldblatt; Cynthia G Whitney; Katherine L O'Brien
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

6.  Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?

Authors:  Katherine L O'Brien; David Goldblatt; Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

Review 7.  Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.

Authors:  Laura Conklin; Jennifer D Loo; Jennifer Kirk; Katherine E Fleming-Dutra; Maria Deloria Knoll; Daniel E Park; David Goldblatt; Katherine L O'Brien; Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

Review 8.  The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.

Authors:  Daniel E Park; T Scott Johnson; Bareng Aletta S Nonyane; Subhash Chandir; Laura Conklin; Katherine E Fleming-Dutra; Jennifer D Loo; David Goldblatt; Cynthia G Whitney; Katherine L O'Brien; Maria Deloria Knoll
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

9.  Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.

Authors:  Olumuyiwa O Odusanya; Yetunde A Kuyinu; Omolara A Kehinde; Fakrudeen Shafi; Nancy François; Juan Pablo Yarzabal; Kurt Dobbelaere; Jens U Rüggeberg; Dorota Borys; Lode Schuerman
Journal:  Hum Vaccin Immunother       Date:  2013-12-04       Impact factor: 3.452

10.  Estimating meningitis hospitalization rates for sentinel hospitals conducting invasive bacterial vaccine-preventable diseases surveillance.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-10-04       Impact factor: 17.586
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.